Kisaki T, Leung D Y, Jardieu P, Geha R S, Ishizaka K
Subdepartment of Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.
Eur J Immunol. 1988 Nov;18(11):1663-70. doi: 10.1002/eji.1830181103.
We have previously established human T cell hybridomas which produce IgE-binding factors. Incubation of one of the T cell hybridomas, 166A2, with human IgE dimer in the presence of 1 microgram/ml bradykinin resulted in the formation of IgE-binding factors having affinity for lentil lectin. The factors selectively enhanced both IgE-forming cell responses of rat mesenteric lymph node (MLN) cells and spontaneous IgE synthesis by human peripheral blood B cells of atopic patients, without affecting the IgG response. The same factors that enhanced IgE synthesis of B cells from atopic patients also enhanced IgE synthesis induced under bystander conditions by activated alloreactive T cells. Fractionation of the affinity-purified IgE-binding factors by gel filtration revealed three molecular mass species, i.e., 60 kDa, 30 kDa and 15 kDa. The 60-kDa and 15-kDa IgE-binding factors selectively enhanced both the spontaneous IgE synthesis by B cells of atopic patients and IgE response of rat MLN cells. In contrast, the 30-kDa IgE-binding factors had only marginal enhancing effects on the IgE synthesis by both human B cells and rat MLN cells. When the 166A2 hybridoma cells were incubated with IgE dimer in the presence of glycosylation-inhibiting factor (GIF), essentially all IgE-binding factors formed by the cells had affinity for peanut agglutinin (PNA) but for neither lentil lectin nor concanavalin A. All of the 60-kDa, 30-kDa and 15-kDa species, having affinity for PNA, selectively suppressed the potentiating factor-enhanced IgE response of rat MLN cells. The factors also suppressed the IgE synthesis of human B cells from atopic patients when the synthesis was enhanced by IgE-potentiating factor. The results indicate that human IgE-binding factors regulate IgE synthesis by both human and rat lymphocytes.
我们之前已建立了产生IgE结合因子的人T细胞杂交瘤。在存在1微克/毫升缓激肽的情况下,将其中一种T细胞杂交瘤166A2与人IgE二聚体一起孵育,导致形成了对扁豆凝集素具有亲和力的IgE结合因子。这些因子选择性地增强了大鼠肠系膜淋巴结(MLN)细胞的IgE形成细胞反应以及特应性患者人外周血B细胞的自发IgE合成,而不影响IgG反应。增强特应性患者B细胞IgE合成的相同因子,也增强了同种异体反应性T细胞在旁观者条件下诱导的IgE合成。通过凝胶过滤对亲和纯化的IgE结合因子进行分级分离,揭示了三种分子量的物质,即60 kDa、30 kDa和15 kDa。60 kDa和15 kDa的IgE结合因子选择性地增强了特应性患者B细胞的自发IgE合成以及大鼠MLN细胞的IgE反应。相比之下,30 kDa的IgE结合因子对人B细胞和大鼠MLN细胞的IgE合成仅具有微弱的增强作用。当166A2杂交瘤细胞在存在糖基化抑制因子(GIF)的情况下与IgE二聚体一起孵育时,细胞形成的基本上所有IgE结合因子都对花生凝集素(PNA)具有亲和力,但对扁豆凝集素或伴刀豆球蛋白A均无亲和力。所有对PNA具有亲和力的60 kDa、30 kDa和15 kDa物质,都选择性地抑制了增强因子增强的大鼠MLN细胞的IgE反应。当IgE增强因子增强特应性患者人B细胞的IgE合成时,这些因子也抑制了其IgE合成。结果表明,人IgE结合因子调节人和大鼠淋巴细胞的IgE合成。